Navrogen Revenue and Competitors
Estimated Revenue & Valuation
- Navrogen's estimated annual revenue is currently $387.5k per year.
- Navrogen's estimated revenue per employee is $77,500
- Navrogen's total funding is $6.2M.
Employee Data
- Navrogen has 5 Employees.
- Navrogen grew their employee count by 0% last year.
Navrogen's People
| Name | Title | Email/Phone |
|---|---|---|
1 | CEO and Co-founder | Reveal Email/Phone |
2 | VP Finance & Operations | Reveal Email/Phone |
3 | Chief Scientific Officer | Reveal Email/Phone |
Navrogen Competitors & AlternativesAdd Company
| Competitor Name | Revenue | Number of Employees | Employee Growth | Total Funding | Valuation |
|---|---|---|---|---|---|
#1 | $1.6M | 10 | 0% | N/A | N/A |
#2 | $4M | 26 | 13% | N/A | N/A |
#3 | $0.9M | 6 | -14% | N/A | N/A |
#4 | $1.1M | 7 | 0% | N/A | N/A |
#5 | $10.9M | 70 | 3% | N/A | N/A |
#6 | $0.7M | 9 | 29% | N/A | N/A |
#7 | $4M | 26 | -16% | N/A | N/A |
#8 | $1.7M | 11 | 22% | N/A | N/A |
#9 | $7.6M | 49 | 2% | N/A | N/A |
#10 | $1.6M | 10 | 0% | N/A | N/A |
What Is Navrogen?
Navrogen Inc. is a biopharmaceutical company focused on the targeted treatment of cancer. Navrogen is currently working on enhancing the immune system to fight cancer by removing the effect of factors produced or induced by tumor cells which inhibit the cancer-fighting humoral immune system.
keywords:N/A
$6.2M
Total Funding
5
Number of Employees
$387.5k
Revenue (est)
0%
Employee Growth %
N/A
Valuation
N/A
Accelerator
Navrogen News
2022-03-22 - Navrogen Presents Preclinical Data on Its NAV-001 Antibody-Drug ...
CHEYNEY, Pa., March 28, 2022 /PRNewswire/ -- Navrogen, Inc., a biopharmaceutical company specialized in developing therapies for cancer and...